Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05114564 · ClinicalTrials.gov registry record · NA

Evaluation of the Performance of Monthly Replacement Sphere Lens Designs in Habitual Soft Contact Lens Wearers

A NA study, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
66
Enrollment target

NCT05114564 is a NA study that has completed, run by CooperVision. The registered enrollment target is 66 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05114564, a NA study, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target

Study Summary

The objective of the study is to evaluate the clinical performance of two monthly silicone hydrogel contact lenses in habitual wearers of frequent replacement (FRP) lenses when worn for one month.

Interventions

  • DEVICE Lens A (comfilcon A lens)
  • DEVICE Lens B (lehfilcon A lens)

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2021-11-19
Est. Completion 2022-04-22
Phase NA

Sponsor

CooperVision

64 total trials

What the Registry Record Tells You About NCT05114564

The ClinicalTrials.gov registry entry for NCT05114564 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Lens A (comfilcon A lens) is the first listed.

NCT05114564 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05114564 about?

NCT05114564 is a clinical study titled "Evaluation of the Performance of Monthly Replacement Sphere Lens Designs in Habitual Soft Contact Lens Wearers". The objective of the study is to evaluate the clinical performance of two monthly silicone hydrogel contact lenses in habitual wearers of frequent replacement (FRP) lenses when worn for one month.

What is the current status of trial NCT05114564?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2021-11-19. Estimated completion is 2022-04-22.

What interventions are being tested in trial NCT05114564?

The interventions under investigation include: Lens A (comfilcon A lens) (DEVICE), Lens B (lehfilcon A lens) (DEVICE).

Who is sponsoring clinical trial NCT05114564?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.